PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26787031-7	2016	RESULTS: Scl-AbIII or raloxifene treatment produced significant increase of serum BSAP, osteocalcin, IGF-1, PTH and Ca2+ levels.	Raloxifene Hydrochloride	22-32	bone gamma-carboxyglutamate protein	Rattus norvegicus	88-99	
26787031-9	2016	Combination therapy of Scl-AbIII, and raloxifene produced significant increase of serum alkaline phosphatase, osteocalcin and IGF-1 levels than treatment with either Scl-AbIII or raloxifene alone.	Raloxifene Hydrochloride	38-48	bone gamma-carboxyglutamate protein	Rattus norvegicus	110-121	
20428990-15	2010	Both estradiol and RLX produced conflicting effects on serum ALP, osteocalcin, and PTH levels in both animal models.	Raloxifene Hydrochloride	19-22	bone gamma-carboxyglutamate protein	Rattus norvegicus	66-77	
20036346-0	2010	Osteocalcin immunolabeling during the alveolar healing process in ovariectomized rats treated with estrogen or raloxifene.	Raloxifene Hydrochloride	111-121	bone gamma-carboxyglutamate protein	Rattus norvegicus	0-11	
20036346-1	2010	The influence of an estrogen-deficient state was evaluated in this study and also its treatments with estrogen (E(2)) or with raloxifene (RLX) on the expression of osteocalcin during the periods of the chronology of the alveolar bone healing process (7, 14, 21, 28 and 42 post-extraction days) by means of immunohistochemistry reactions and histomorphometric analysis.	Raloxifene Hydrochloride	126-136	bone gamma-carboxyglutamate protein	Rattus norvegicus	164-175	
20036346-1	2010	The influence of an estrogen-deficient state was evaluated in this study and also its treatments with estrogen (E(2)) or with raloxifene (RLX) on the expression of osteocalcin during the periods of the chronology of the alveolar bone healing process (7, 14, 21, 28 and 42 post-extraction days) by means of immunohistochemistry reactions and histomorphometric analysis.	Raloxifene Hydrochloride	138-141	bone gamma-carboxyglutamate protein	Rattus norvegicus	164-175	
19802678-12	2009	Among female groups with OSs, 10-6 M raloxifene significantly increased ALP activity, calcium content, and osteocalcin content compared with the controls.	Raloxifene Hydrochloride	37-47	bone gamma-carboxyglutamate protein	Rattus norvegicus	107-118	
16059775-4	2005	Raloxifene lowered total cholesterol, LDL-C, osteocalcin, and urinary deoxypyridinoline levels to below Ovx levels, while having no effect on estrogen levels.	Raloxifene Hydrochloride	0-10	bone gamma-carboxyglutamate protein	Rattus norvegicus	45-56